صحافة بلادي صحيفة إلكترونية مغاربية متجددة على مدار الساعة تعنى بشؤون المغرب الجزائر ليبيا موريتانيا تونس
Tunisia –The recent increases in the prices of about 300 medicines in Tunisia sparked a wide wave of controversy, amid warnings of their repercussions on patients, especially those suffering from chronic diseases, at a time when experts and organizations confirm that the crisis goes beyond the issue of prices to include structural imbalances in the medicine system and its financing.
According to the available data, the price review included a number of essential medicines, as the “ALART” organization considered that some of the increases were significant, stressing that the decision was not preceded by an official announcement or communication plan explaining its reasons and mechanisms to accompany it, despite its acknowledgment that the prices of some medicines did not reflect the current import and production costs.
The organization attributed these developments to the financial pressures faced by the Tunisian central pharmacy, as a result of the high cost of supply and the accumulation of debts, calling for a comprehensive reform of the drug pricing system that balances the sustainability of the sector and ensuring the right of citizens to treatment, taking into account the purchasing power of families.
For their part, Representative Muhammad Ali expressed his refusal to burden patients with the cost of the crisis, considering that reforming the sector must start from addressing structural imbalances in financing and governance, while calling for the government to be held accountable regarding the foundations on which the decision to increase was based and the accompanying measures to protect vulnerable groups and patients with chronic diseases.
Economist Reda Al-Shakandali also believed that the rise in drug prices raises questions about the state’s ability to maintain its social role, warning that continued financial pressures may affect the availability of some medicines in the future, which requires adopting a comprehensive national policy to enhance drug security and ensure the continuity of supply of essential medicines.
On the other hand, the Tunisian Syndicate of Private Pharmacy Owners stressed that reviewing prices must be based on clear standards, taking into account the purchasing power of the citizen and ensuring the continuity of the provision of medicines and the continuity of the work of pharmacies, indicating that it was not involved in the recent decision.
Source:“My press”
